Jennifer Pietenpol Archives
Jun. 28, 2018—A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives.
Oct. 19, 2017—Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.
Jul. 27, 2017—On the same day 48 years after the July 20, 1969, Apollo 11 moon landing, individuals from throughout the Vanderbilt community reflected on that historic event — a milestone marking the ultimate synthesis of innovative thinking and technology — as they shared their own explorations and mission moments during StrategyShare17.
May. 19, 2017—The second School of Medicine Research Enterprise Forum is scheduled from 3 to 5 p.m. Tuesday, May 30, in Light Hall, Room 208. Jennifer Pietenpol, Vanderbilt University Medical Center executive vice president for research, will host the event.
May. 11, 2017—Nearly 400 members of the Canby Robinson Society and the Vanderbilt University Medical Center (VUMC) community joined together at Cheekwood Estate and Gardens recently for a reception celebrating the Medical Center’s shared commitment to healthy communities and to pioneer the future of health care.
Apr. 6, 2017—Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen.
Feb. 6, 2017—The 2017 class of Chancellor Faculty Fellows comprises highly accomplished, recently tenured faculty from across the university.
Feb. 2, 2017—Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection.